Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice
Author(s) -
Xia Wen Shui,
Talba Tahirou,
Qinyan Cheng,
Xin Tian
Publication year - 2011
Publication title -
diabetes metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s18025
Subject(s) - chelation , cobalt , streptozotocin , diabetes mellitus , chemistry , in vivo , food intake , toxicity , pharmacology , oral administration , medicine , endocrinology , biochemistry , biology , inorganic chemistry , microbiology and biotechnology
The purpose of this study was to assess the in vivo ability of glucosaminic acid-cobalt (II) chelate to reduce glycemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom